Hamura, Japan

Ryoji Masubuchi


Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 387(Granted Patents)


Location History:

  • Hachioji, JP (1997)
  • Hamura, JP (1998 - 2000)

Company Filing History:


Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ryoji Masubuchi: Innovator in Medical Technology

Introduction

Ryoji Masubuchi is a notable inventor based in Hamura, Japan. He has made significant contributions to the field of medical technology, particularly in the development of systems for evulsing subcutaneous tissue. With a total of 3 patents to his name, Masubuchi's work is recognized for its innovative approach to surgical procedures.

Latest Patents

One of Masubuchi's latest patents is a system designed for evulsing subcutaneous tissue. This system includes an endoscope that can be inserted into subcutaneous tissue through a small incision to observe the tissue that needs to be evulsed. It features a dissecting unit that dissects the tissue from surrounding areas, creating a cavity for treatment. Additionally, a cavity maintaining unit is used to retain the treatment space, allowing for the insertion and removal of the endoscope and treatment tools necessary for the procedure.

Career Highlights

Ryoji Masubuchi is currently employed at Olympus Optical Company, Ltd., where he continues to innovate in the medical field. His work has contributed to advancements in minimally invasive surgical techniques, enhancing patient care and recovery.

Collaborations

Masubuchi has collaborated with notable coworkers, including Ryoichi Konou and Jin Kira. Their combined expertise has fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Ryoji Masubuchi's contributions to medical technology through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact surgical practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…